Relyvrio is a combination medication containing sodium phenylbutyrate and taurursodiol. It's FDA-approved to help slow down the worsening of symptoms in people with amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease. It appears to lengthen life expectancy for people with ALS, but a larger clinical trial is still being conducted to confirm this. Relyvrio comes as a packet of powder that you mix with water and take by mouth or through a feeding tube. Common side effects include diarrhea, stomach pain, nausea, and sometimes a bitter taste in your mouth after you take the medication.
Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease
Relyvrio is a combination of two medications, sodium phenylbutyrate and taurursodiol. While it's not fully known how it works to treat ALS, researchers think this medication helps stop neurons (brain cells) from dying.
Source: DailyMed
Combines two medications into one packet for convenience
Available as a powder packet that's mixed with water, which is easier to swallow than pills
Can slow the worsening of symptoms in people with ALS
Can be given through a feeding tube
Brand only
Can cause a lot of stomach-related side effects (e.g., diarrhea, nausea, stomach pain)
Can interact with many medications, such as certain cholesterol medications and antacids
Might not be the best choice for people who need a low-sodium (salt) diet
Before taking your dose of Relyvrio, make sure to mix the powder that's inside of the packet with 8 oz (or 1 cup) of room temperature water. Once you've mixed the medication for your dose, you can keep your dose at room temperature for up to 1 hour. After this time, throw away any remaining medication because it might not work as well anymore.
Take your dose of Relyvrio before a snack or meal. Taking the medication with food helps your body absorb it safely and properly.
Relyvrio contains a high amount of sodium (salt). Let your provider know if you have heart or kidney problems or if you're following a low-sodium diet before taking this medication.
Check with your pharmacist or provider before starting any new medications so they can make sure your medications are safe to take with Relyvrio. Relyvrio has many potential interactions with other medications.
Tell your provider if you're pregnant, planning on becoming pregnant, or breastfeeding. Your provider can discuss the risks and benefits of taking Relyvrio. There isn't enough information to know if Relyvrio can cause harm when taken during pregnancy or while breastfeeding. But in animal studies, the medication caused harm to babies when taken by pregnant or breastfeeding animals at doses similar to recommended doses in humans.
Store Relyvrio at room temperature. Make sure to keep it sealed in its original container until you're ready to take your dose. This will help protect the powder from moisture, which can affect how well the medication works for you.
Relyvrio can cause some serious health issues. This risk may be even higher for certain groups. If this worries you, talk to your doctor or pharmacist about other options.
Risk factors: Liver, pancreas, or intestinal (gut) problems
If you have a medical condition that interrupts the flow of bile acid in your body (e.g., gallbladder problems), then taking Relyvrio can cause you to have worsening diarrhea. This is because Relyvrio contains a bile acid (taurursodiol), which can build up in your gut. In addition, if you have other problems related to the pancreas or intestines (e.g., malabsorption), your body might have trouble absorbing Relyvrio. This means that this medication won't work as well for you. Let your provider know if you have any of the conditions listed above. If you experience new or worsening diarrhea, contact your provider.
Risk factors: Heart failure | High blood pressure | Kidney problems
Relyvrio contains a high amount of salt; each packet contains 464 mg of sodium. Too much salt could worsen certain medical conditions, like heart failure, high blood pressure, and kidney problems. Discuss your full medical history with your provider so they can help decide if Relyvrio is safe for you to take. In some cases, you might need to keep a closer eye on your salt intake while you're taking Relyvrio.
Each packet contains 3 grams of sodium phenylbutyrate and 1 gram of taurursodiol.
The typical starting dose is 1 packet mixed with 8 oz (or 1 cup) of water once daily for 3 weeks. The mixture is taken by mouth or through a feeding tube. After the first 3 weeks, your provider will raise your dose to 1 packet taken twice daily.
Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease
By signing up, I agree to GoodRx's Terms and Privacy Policy, and to receive marketing messages from GoodRx.
Amylyx Pharmaceuticals Inc. (2022). Relyvrio- sodium phenylbutyrate/taurusodiol powder, for suspension [package insert]. DailyMed.
Amylyx Pharmaceuticals Inc. (2023). Phase III trial of AMX0035 for amyotrophic lateral sclerosis treatment (Phoenix). ClinicalTrials.gov.
Amylyx Pharmaceuticals Inc. (2024). Relyvrio- sodium phenylbutyrate/taurusodiol powder, for suspension [package insert]. DailyMed.
Amylyx Pharmaceuticals Inc. (n.d.). Let’s get started.
Jamieson, N. C., et al. (2023). Feeding tube. StatPearls.
MedlinePlus. (2022). Bile.
National Institute of Neurological Disorders and Stroke. (2023). Amyotrophic lateral sclerosis (ALS).
Paganoni, S., et al. (2020). Long-term survival of participants in the CENTAUR trial of sodium phenylbutyrate-taurursodiol in amyotrophic lateral sclerosis. Muscle & Nerve.
Paganoni, S., et al. (2020). Trial of sodium phenylbutyrate-taurursodiol for amyotrophic lateral sclerosis. The New England Journal of Medicine.
Zuvarox, T., et al. (2023). Malabsorption syndromes. StatPearls.
Research prescriptions and over-the-counter medications from A to Z, compare drug prices, and start saving.